Research

Allison receives Nobel Prize in Sweden for immunotherapy innovation

James P. Allison, Ph.D., delivered his Nobel Lecture on Dec. 7 at the Karolinska Institutet in Stockholm


By Cindy George | December 10, 2018

UPDATED on Dec. 11, 2018 with photo from the Dec, 10, 2018 ceremony.

ORIGINAL STORY: James P. Allison, Ph.D., an immunologist at The University of Texas MD Anderson Cancer Center, is in Sweden to receive the 2018 Nobel Prize in Physiology or Medicine jointly with Japanese immunologist Tasuku Honjo, M.D., Ph.D.

The ceremony begins at 9:30 a.m. Houston time at the Stockholm Concert Hall and will be live-streamed here.

The pair were announced on Oct. 1 as laureates for the discovery of cancer therapies that stimulate the immune system to attack tumor cells. Treatments developed from Allison’s work have extended the lives of thousands of people with advanced disease, though certain cancers have responded better to immunotherapy than others.

Allison delivered his Nobel lecture entitled “Immune Checkpoint Blockade in Cancer Therapy: New insights, opportunities, and prospects for cures” on Dec. 7 in Stockholm.

Both Allison, 70, and Honjo, 76, made discoveries that led to the development of “checkpoint inhibitors”—drugs infused into patients to block molecules that put the brakes on T cells. By releasing these brakes, the body’s own immune system is able to fight cancer.

Each scientist will receive a Nobel medal and diploma. They will also share a nearly $1 million prize.

According to MD Anderson, Allison has been busy during Nobel Week in Sweden. On Thursday, he signed the bottom of a chair at Bistro Nobel in the Nobel Museum in Stockholm’s Old Town. The ritual is part of a traditional museum visit by Nobel winners and launches the week’s events.

Laureates traditionally donate artifacts to the Nobel Museum. Allison presented the museum with the following items:

  • A vial representing 9H10, a mouse-model monoclonal antibody developed in his lab in 1995 to block CTLA-4, a protein on T cells that shuts down immune response
  • A vial of ipilimumab from Bristol-Myers Squibb that was developed for human use based on Allison’s work
  • The first page of a 1996 article in Science that reported the success of anti-CTLA-4 treatment in freeing T cells to attack cancer in mice
  • The first page of a 2015 review in Cell that was co-authored by Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at MD Anderson, who is the scientist’s longtime research collaborator and spouse
  • A portrait of Allison and Sharma taken by a Dallas photographer

Allison is the first Nobel laureate for MD Anderson, where he is a professor and chair of the department of immunology. He is the executive director of the Immunotherapy Platform, which is part of MD Anderson’s Moon Shots Program—an ambitious effort to more rapidly reduce cancer deaths and suffering by developing advances in prevention, early detection and treatment based on scientific discoveries. In addition, Allison holds the Vivian L. Smith Distinguished Chair in Immunology and serves as deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers in the department of genitourinary medical oncology.

Read more about Allison in this profile published in the November 2018 issue of TMC Pulse.

 




Social Posts

profile_image

Veterans Affairs

@DeptVetAffairs

An Oral History Boom: Hundreds of Groups Are Recording Veterans' Stories https://t.co/KZ7WTC1cPM via @wunc

1 hour ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

ICYMI: Research shows small cell #lungcancer may respond to combination of #immunotherapy and DNA damage repair inhibitors https://t.co/eVvxKI367M #endcancer

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

ISU offering free legal clinic for service members and Veterans https://t.co/m8a8DfczL5 via @localnews8

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Iraq, Afghanistan and Persian Gulf Veterans sought to take part in last honor flight by Omaha group https://t.co/WuwJltI2P5 via @sbstarherald

3 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

What happens to your body when you overeat? https://t.co/AyLIiWQACi via @focusedonhealth #endcancer

4 hours ago
profile_image

University of Houston

@UHouston

RT @UHpres: How about that...Cougars beat USF and take their 26th win of the season!

4 hours ago
profile_image

University of Houston

@UHouston

RT @UHCougarMBK: No 9/8 COOGS WIN!!! Final score presented by @thejointchiro UH moves to 2️⃣6️⃣-1️⃣ overall 1️⃣3️⃣-1️⃣ in #AmericanHoops…

5 hours ago
profile_image

University of Houston

@UHouston

RT @UHpres: Have to watch this game on IPhone... https://t.co/n7LZL6y3UD

5 hours ago
profile_image

Rice University

@RiceUniversity

@SylvesterTurner @RiceAthletics @ConferenceUSA @RiceWBB 💙🦉

6 hours ago
profile_image

Rice University

@RiceUniversity

RT @RiceAthletics: 🚨 YOU HEARD IT HERE FIRST! @HoustonTX Mayor @SylvesterTurner will be in attendance for the final @RiceWBB home game of…

6 hours ago
profile_image

Rice University

@RiceUniversity

Congrats @RiceWBB! 🎉 https://t.co/5tnjE0TjiM

7 hours ago
profile_image

BCMHouston

@bcmhouston

Dr. Chonghui Cheng sits down with @BCMFromtheLabs to talk about how protein CD44 variants prompt different cancer cell behaviors. https://t.co/YOq8f7LIGs #cancer #research

8 hours ago
profile_image

Memorial Hermann

@memorialhermann

Here's 10 creative ways to squeeze a workout into your busy schedule: https://t.co/4rqaXtZo0w. #HeartMonth https://t.co/b4DcazpBdO

8 hours ago
profile_image

BCMHouston

@bcmhouston

RT @bcmgcprogram: @bcmgcprogram faculty member Michael Wangler (@mfwangler) was the featured event speaker at today’s @rarediseaseday Houst…

9 hours ago
profile_image

UTHealth

@UTHealth

The Maternal and Child Health Training Program team at UTHealth is working to integrate community health workers into the spectrum of maternal and child health care. Learn more in this @TXHealthJournalstory: https://t.co/zRITDTDJVX #ManyFacesOfUTHealth

11 hours ago